{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:26:48Z","timestamp":1787005608656,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Through a more precise and safer means of diagnosing foetal aneuploidies, non-invasive prenatal testing (NIPT) with cell-free DNA (cfDNA) has revolutionized prenatal screening and removed the necessity of invasive diagnostic procedures. The aim of the systematic review was to determine the limits of, diagnostic accuracies, and clinical value of cfDNA-based NIPT in different foetal aneuploidies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of studies assessing the diagnostic performance of cfDNA-based NIPT for detecting Trisomy 21 (T21), Trisomy 18 (T18), Trisomy 13 (T13), sex chromosome aneuploidies (SCA), and copy number variations (CNVs)The studies included were prospective, retrospective, or diagnostic accuracy studies that compared cfDNA results with invasive prenatal diagnostic tests, including amniocentesis, CVS, karyotyping, and chromosomal microarray analysis (CMA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of studies reviewed was 20, and it involved a total of more than 67,500 individuals. NIPT utilizing cfDNA has proven sensitive and specific in T21, T18, and T13 and an excellent accuracy level in most risk populations. In the case of T21 there was 100% sensitivity and 100% specificity of cfDNA in various studies. For Trisomy 18 the sensitivity was between 92.3% to 100% with a high mean specificity of 99.6%\u2013100%. The sensitivity was also good, with Trisomy 13 diagnostic performance, as it lies between 78.6% and 100% and a specificity of 99.8 to 100 percent. However, SCA and CNVs showed more variable performance with a sensitivity of between 75 to 100 per cent in SCA and between 53.6 and 97.7 per cent, respectively. The presence of discordant outcomes, particularly in relation to SCA and microdeletions, was a problem area and underscored the importance of genetic counseling and standardized procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>cfDNA-based NIPT is a highly effective and non-invasive tool for screening common trisomies but has limitations in detecting SCA and CNVs. While the screening\u2019s integration into clinical practice is beneficial, it is essential to address the limitations of discordant results and the psychological impacts on patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261277611<\/jats:ext-link>\n                      , identifier CRD420261277611.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1886738","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:10:23Z","timestamp":1787004623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of cell-free DNA-based non-invasive prenatal testing for fetal aneuploidies: a systematic review"],"prefix":"10.3389","volume":"17","author":[{"given":"Sharif","family":"Alhajlah","sequence":"first","affiliation":[{"name":"Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University","place":["Shaqra, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.31083\/j.ceog5010220","article-title":"Knowledge and attitude regarding non-invasive prenatal testing (NIPT) among women: a cross-sectional study in Saudi Arabia","volume":"50","author":"Bahkali","year":"2023","journal-title":"Clin. Exp. Obstet. Gynecol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/genes12010015","article-title":"Non-invasive prenatal testing: current perspectives and future challenges","volume":"12","author":"Carbone","year":"2020","journal-title":"Genes (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.12891\/ceog4242.2018","article-title":"Non-invasive prenatal screening for fetal aneuploidy in twin pregnancies by cell-free DNA analysis","volume":"45","author":"Chen","year":"2018","journal-title":"Clin. Exp. Obstet. Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1682161","DOI":"10.3389\/fmed.2025.1682161","article-title":"Editorial: advancements in prenatal diagnosis: from noninvasive prenatal tests to novel fetal imaging","volume":"12","author":"Cohen","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.23736\/S0026-4784.18.04306-X","article-title":"Update in non-invasive prenatal testing","volume":"71","author":"D\u2019ambrosio","year":"2019","journal-title":"Minerva Ginecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jemep.2016.07.006","article-title":"\u201cI think we\u2019ve got too many tests!\u201d: prenatal providers\u2019 reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening","volume":"2","author":"Gammon","year":"2016","journal-title":"Ethics Med. Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41436-021-01147-4","article-title":"Utility of noninvasive genome-wide screening: a prospective cohort of obstetric patients undergoing diagnostic testing","volume":"23","author":"Guseh","year":"2021","journal-title":"Genet. Med."},{"key":"B10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5734\/JGM.2015.12.2.85","article-title":"Non-invasive prenatal testing of fetal chromosomal aneuploidies by massively parallel sequencing of maternal plasma DNA","volume":"12","author":"Han","year":"2015","journal-title":"J. Genet. Med."},{"key":"B11","volume-title":"Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation","author":"Hardisty","year":"2016"},{"key":"B12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pd.4338","article-title":"Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction: non-invasive risk assessment of fetal sex chromosome aneuploidy","volume":"34","author":"Hooks","year":"2014","journal-title":"Prenat. Diagn"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3390\/diagnostics13152570","article-title":"Non-invasive prenatal testing (NIPT): reliability, challenges, and future directions","volume":"13","author":"Jayashankar","year":"2023","journal-title":"Diagn. (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/genes12101593","article-title":"Performance of non-invasive prenatal screening for fetal aneuploidy in 83,671 pregnancies: a large-scale retrospective study","volume":"12","author":"Lai","year":"2021","journal-title":"Genes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/gim.2013.149","article-title":"Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies","volume":"16","author":"Lambert-Messerlian","year":"2014","journal-title":"Genet. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"227.e1","DOI":"10.1016\/j.ajog.2016.02.030","article-title":"Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants","volume":"215","author":"Lefkowitz","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.1321997111","article-title":"Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing","volume":"111","author":"Liao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/pd.4127","article-title":"Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma: noninvasive prenatal detection of sex chromosome aneuploidy by MPS","volume":"33","author":"Mazloom","year":"2013","journal-title":"Prenat. Diagn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"214.e1","DOI":"10.1016\/j.ajog.2015.04.001","article-title":"Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings","volume":"213","author":"Meck","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-biodatasci-020722-094144","article-title":"Noninvasive prenatal testing using circulating DNA and RNA: advances, challenges, and possibilities","volume":"6","author":"Moufarrej","year":"2023","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12884-022-05224-7","article-title":"Factors affecting low fetal fraction in fetal screening with cell-free DNA in pregnant women: a systematic review and meta-analysis","volume":"22","author":"Mousavi","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/pd.4103","article-title":"Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y: validation study of cfDNA testing using SNPs","volume":"33","author":"Nicolaides","year":"2013","journal-title":"Prenat. Diagn"},{"key":"B23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/AOG.0000000000000363","article-title":"Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort","volume":"124","author":"Pergament","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/genes15121590","article-title":"A decade of non-invasive prenatal testing (NIPT) for chromosomal abnormalities in Croatia: first national monocentric study to inform country's future prenatal care strategy","volume":"15","author":"Podobnik","year":"2024","journal-title":"Genes (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"365.e1","DOI":"10.1016\/j.ajog.2014.03.042","article-title":"Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA","volume":"211","author":"Porreco","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/pd.4159","article-title":"SNP-Based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy: non-invasive prenatal testing detects sex chromosome aneuploidies","volume":"33","author":"Samango-Sprouse","year":"2013","journal-title":"Prenat. Diagn"},{"key":"B27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/uog.13460","article-title":"Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy","volume":"45","author":"Song","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1654","DOI":"10.1002\/mgg3.1654","article-title":"Non-invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"9","author":"Soukkhaphone","year":"2021","journal-title":"Mol. Genet. Genomic Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13039-020-0478-5","article-title":"Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma","volume":"13","author":"Wang","year":"2020","journal-title":"Mol. Cytogenet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/uog.13361","article-title":"Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital: SCA detection in a Chinese hospital","volume":"44","author":"Yao","year":"2014","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.15419\/bmrat.v12i5.980","article-title":"Non-invasive prenatal testing: advances, applications, and limitations in prenatal screening","volume":"12","author":"Yu","year":"2025","journal-title":"Biomed. Res. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"864076","DOI":"10.3389\/fgene.2022.864076","article-title":"Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fgene.2019.00069","article-title":"Comparison of efficiencies of non-invasive prenatal testing, karyotyping, and chromosomal micro-array for diagnosing fetal chromosomal anomalies in the second and third trimesters","volume":"10","author":"Zhu","year":"2019","journal-title":"Front. Genet."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1886738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:10:25Z","timestamp":1787004625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1886738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":33,"alternative-id":["10.3389\/fgene.2026.1886738"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1886738","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1886738"}}